Skip to main content
Premium Trial:

Request an Annual Quote

Firm Helps Bioinformatics Companies Plan Strategies

Premium

MORAGA, Calif.--HighTech Business Decisions, a new company here devoted to helping electronics and biotechnology companies determine successful business development strategies, will focus on bioinformatics as one of its key markets, according to founder and president Sandra Fox. "Biotech nology markets are expanding into areas such as bioinformatics, high-throughput screening assays for new biopharmaceuticals, and scale-up manufacturing," she observed. "Contract manufacturing has become an important strategy. HighTech Business Decisions is in position to track these business-to-business markets as they evolve and help clients increase sales."

The new firm will match industry specialists who have PhD's or MBA's with clients in need of customized market research, Fox explained. HighTech has a web site at http://www.hitechbiz.com.

Filed under

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.